<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>haploinsufficiency therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/haploinsufficiency-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 27 Oct 2025 23:20:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>haploinsufficiency therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Scripps Research Secures $4 Million to Enhance Platform Targeting Neurodevelopmental Disorders</title>
		<link>https://bioengineer.org/scripps-research-secures-4-million-to-enhance-platform-targeting-neurodevelopmental-disorders/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 27 Oct 2025 23:20:09 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CIRM grant funding]]></category>
		<category><![CDATA[gene expression restoration]]></category>
		<category><![CDATA[haploinsufficiency therapy]]></category>
		<category><![CDATA[induced pluripotent stem cells]]></category>
		<category><![CDATA[neurodevelopmental disorders]]></category>
		<guid isPermaLink="false">https://bioengineer.org/scripps-research-secures-4-million-to-enhance-platform-targeting-neurodevelopmental-disorders/</guid>

					<description><![CDATA[In a groundbreaking advancement at the intersection of regenerative medicine and neurobiology, researchers at Scripps Research have embarked on an ambitious project aimed at addressing some of the most challenging neurodevelopmental disorders. These disorders often arise from a genetic phenomenon known as haploinsufficiency, where a single functional copy of a gene fails to produce sufficient [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">287462</post-id>	</item>
	</channel>
</rss>
